Lataa...
Systemic Tofacitinib Concentrations in Adult Patients With Atopic Dermatitis Treated With 2% Tofacitinib Ointment and Application to Pediatric Study Planning
Atopic dermatitis is a chronic eczematous, pruritic, inflammatory skin condition affecting children and adults. Tofacitinib is a Janus kinase inhibitor. The efficacy, safety, and pharmacokinetics of 2% tofacitinib ointment twice daily have been evaluated in a 4‐week phase 2a multisite randomized, do...
Tallennettuna:
| Julkaisussa: | J Clin Pharmacol |
|---|---|
| Päätekijät: | , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
John Wiley and Sons Inc.
2018
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6590358/ https://ncbi.nlm.nih.gov/pubmed/30556911 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jcph.1360 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|